These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 34099630)

  • 21. A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos.
    Rankin-Turner S; Vader P; O'Driscoll L; Giebel B; Heaney LM; Davies OG
    Adv Drug Deliv Rev; 2021 Jun; 173():479-491. PubMed ID: 33862168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity.
    Gudbergsson JM; Jønsson K; Simonsen JB; Johnsen KB
    J Control Release; 2019 Jul; 306():108-120. PubMed ID: 31175896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomimetic and bioinspired nanoparticles for targeted drug delivery.
    Gagliardi M
    Ther Deliv; 2017 Mar; 8(5):289-299. PubMed ID: 28361608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging prospects of extracellular vesicles for brain disease theranostics.
    Wang R; Wang X; Zhang Y; Zhao H; Cui J; Li J; Di L
    J Control Release; 2022 Jan; 341():844-868. PubMed ID: 34953980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.
    Beh CY; Prajnamitra RP; Chen LL; Hsieh PC
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
    Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
    Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell membrane-coated abiotic nanomaterials for biomedical applications.
    Ferreira-Faria I; Yousefiasl S; Macário-Soares A; Pereira-Silva M; Peixoto D; Zafar H; Raza F; Faneca H; Veiga F; Hamblin MR; Tay FR; Gao J; Sharifi E; Makvandi P; Paiva-Santos AC
    J Control Release; 2022 Nov; 351():174-197. PubMed ID: 36103910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication.
    Mengyuan H; Aixue L; Yongwei G; Qingqing C; Huanhuan C; Xiaoyan L; Jiyong L
    J Nanobiotechnology; 2024 Oct; 22(1):604. PubMed ID: 39370518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in next-generation lipid-polymer hybrid nanocarriers with emphasis on polymer-modified functional liposomes and cell-based-biomimetic nanocarriers for active ingredients and fractions from Chinese medicine delivery.
    Liu Y; Xie X; Chen H; Hou X; He Y; Shen J; Shi J; Feng N
    Nanomedicine; 2020 Oct; 29():102237. PubMed ID: 32534047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in Nanoparticles as Anticancer Drug Delivery Vector: Need of this Century.
    Ali I; Mukhtar SD; Ali HS; Scotti MT; Scotti L
    Curr Pharm Des; 2020; 26(15):1637-1649. PubMed ID: 32013826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harnessing extracellular vesicle membrane for gene therapy: EVs-biomimetic nanoparticles.
    Briffault E; Garcia-Garcia P; Martinez-Borrajo R; Evora C; Delgado A; Diaz-Rodriguez P
    Colloids Surf B Biointerfaces; 2024 Jul; 239():113951. PubMed ID: 38759295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted Drug Delivery in Brain Tumors-nanochemistry Applications and Advances.
    Ganjeifar B; Morshed SF
    Curr Top Med Chem; 2021 Oct; 21(14):1202-1223. PubMed ID: 33185163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altering the landscape of viruses and bionanoparticles.
    Lee LA; Nguyen HG; Wang Q
    Org Biomol Chem; 2011 Sep; 9(18):6189-95. PubMed ID: 21750835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Chitosan Nanoparticles in Cancer Treatment.
    Fu S; Xia J; Wu J
    J Biomed Nanotechnol; 2016 Aug; 12(8):1585-603. PubMed ID: 29341581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
    Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
    Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments.
    Castro F; Martins C; Silveira MJ; Moura RP; Pereira CL; Sarmento B
    Adv Drug Deliv Rev; 2021 Mar; 170():312-339. PubMed ID: 32946921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.